Analysts Set NewAmsterdam Pharma (NASDAQ:NAMS) Price

Dec 26, 2024 · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) has received a consensus recommendation of "Buy" from the six brokerages that are covering the stock, …

CouponFollow Extension

$35.00
OFF

Analysts Set NewAmsterdam Pharma (NASDAQ:NAMS) Price …

3 weeks from now

Jan 23, 2025 · Scotiabank lifted their target price on shares of NewAmsterdam Pharma from $35.00 to $47.00 and gave the stock a “sector outperform” rating in a research report on …

etfdailynews.com

$48.00
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Analyst Ratings, …

3 weeks from now

Jan 1, 2019 · The latest price target for NewAmsterdam Pharma (NASDAQ:NAMS) was reported by HC Wainwright & Co. on January 14, 2025. The analyst firm set a price target for $48.00 …

benzinga.com

$41.60
OFF

NewAmsterdam Pharma (NAMS) Stock Forecast & Price Target

3 weeks from now

4 days ago · NAMS's current price target is $41.60. Learn why top analysts are making this stock forecast for NewAmsterdam Pharma at MarketBeat.

marketbeat.com

$31.00
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating …

3 weeks from now

Dec 26, 2024 · A number of analysts have recently issued reports on NAMS shares. Royal Bank of Canada reiterated an “outperform” rating and set a $31.00 price objective on shares of …

americanbankingnews.com

$33.75
OFF

Expert Ratings For NewAmsterdam Pharma - Nasdaq

3 weeks from now

Sep 23, 2024 · Analysts have set 12-month price targets for NewAmsterdam Pharma, revealing an average target of $33.75, a high estimate of $37.00, and a low estimate of $31.00.

nasdaq.com

$40.00
OFF

RBC Capital Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

6 days ago · RBC Capital analyst Leonid Timashev maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target of $40.00. The …

businessinsider.com

$2
OFF

NewAmsterdam Pharma's SWOT Analysis: Obicetrapib Stock Shows …

3 weeks from now

5 days ago · NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion focused on developing cardiovascular …

investing.com

$945.56
OFF

Beyond The Numbers: 18 Analysts Discuss Regeneron …

3 weeks from now

6 days ago · Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $945.56, a high estimate of $1215.00, and a low estimate of $165.00.

benzinga.com

$27.53
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 1-Year …

3 weeks from now

Jan 8, 2025 · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $27.53 and …

marketbeat.com

1%
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 4.1

3 weeks from now

2 days ago · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) traded up 4.1% during mid-day trading on Friday . The company traded as high as $23.24 and last traded at $22.67. …

marketbeat.com

4%
OFF

Moody Aldrich Partners LLC Sells 137,348 Shares Of …

3 weeks from now

5 days ago · Moody Aldrich Partners LLC trimmed its stake in NewAmsterdam Pharma (NASDAQ:NAMS - Free Report) by 63.4% in the fourth quarter, according to its most recent …

marketbeat.com

FAQs about Analysts Set NewAmsterdam Pharma (NASDAQ:NAMS) Price Coupon?

What are the target prices for newamsterdam pharma's stock?

4 equities research analysts have issued 12 month target prices for NewAmsterdam Pharma's stock. Their NAMS share price forecasts range from $19.00 to $24.00. On average, they predict the company's share price to reach $21.67 in the next year. This suggests a possible upside of 50.7% from the stock's current price. ...

Should you buy newamsterdam Pharma (nap) stock?

Seven investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, NewAmsterdam Pharma presently has a consensus rating of “Buy” and a consensus price target of $38.17. View Our Latest Analysis on NewAmsterdam Pharma Want More Great Investing Ideas? 10 Stocks to Sell NOW! ...

Can HC Wainwright buy newamsterdam Pharma (NAMS) stock?

Investment analysts at HC Wainwright initiated coverage on shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) in a research note issued on Monday, Briefing.com Automated Import reports. The brokerage set a “buy” rating and a $48.00 price target on the stock. ...

Is newamsterdam Pharma (NAMS) a great growth stock in 2023?

NewAmsterdam Pharma's stock was trading at $10.90 on January 1st, 2023. Since then, NAMS stock has increased by 31.9% and is now trading at $14.38. View the best growth stocks for 2023 here. When is NewAmsterdam Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, June 30th 2023. ...

What is the upside for newamsterdam Pharma?

According to analysts' consensus price target of $21.67, NewAmsterdam Pharma has a forecasted upside of 49.7% from its current price of $14.47. NewAmsterdam Pharma has only been the subject of 1 research reports in the past 90 days. ...

How do I receive news & ratings for newamsterdam Pharma?

Receive News & Ratings for NewAmsterdam Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewAmsterdam Pharma and related companies with MarketBeat.com's FREE daily email newsletter. ...